{
    "clinical_study": {
        "@rank": "85659", 
        "arm_group": {
            "arm_group_label": "CMR following ST segment myocardial infarction"
        }, 
        "brief_summary": {
            "textblock": "Cardiac magnetic resonance imaging (CMR) is a non invasive technique used to obtain\n      functional and anatomical information on the heart.  Several CMR parameters measured after\n      primary percutaneous coronary intervention (PPCI) have been shown to have prognostic value\n      and are increasingly being used as surrogate endpoints in clinical trials. Myocardial oedema\n      is a prognostic indicator following myocardial infarction1. Myocardial salvage is calculated\n      as the myocardial oedema minus infarct size; this again is a prognostic indicator following\n      STEMI. However, myocardial oedema imaging is controversial. There are multiple sequences\n      available, with no standardisation of sequences used to assess this surrogate endpoint. The\n      investigators propose to conduct a study to measure the myocardial oedema by all available\n      techniques to determine the agreement between these methods."
        }, 
        "brief_title": "Myocardial Oedema in ST Segment Elevation Myocardial Infarction Myocardial", 
        "condition": [
            "ST Segment Elevation Myocardial Infarction", 
            "Myocardial Oedema"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Edema", 
                "Infarction", 
                "Myocardial Infarction"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  STEMI\n\n          -  providing written informed consent\n\n        Exclusion Criteria:\n\n          -  contraindication to CMR,\n\n          -  atrial fibrillation,\n\n          -  claustrophobia,\n\n          -  eGFR < 30"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "30 patients will be undergo a CMR scan day 2 following STEMI"
            }
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01897350", 
            "org_study_id": "Study 1953"
        }, 
        "intervention": {
            "arm_group_label": "CMR following ST segment myocardial infarction", 
            "intervention_name": "Cardiac magnetic resonance imaging", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "STEMI", 
            "Myocardial edema", 
            "Cardiovascular magnetic resonance"
        ], 
        "lastchanged_date": "July 11, 2013", 
        "location": {
            "contact": {
                "email": "elisa.mcalindon@bristol.ac.uk", 
                "last_name": "Elisa McAlindon, BMBS", 
                "phone": "+441173425888"
            }, 
            "facility": {
                "address": {
                    "city": "Bristol", 
                    "country": "United Kingdom", 
                    "state": "Avon", 
                    "zip": "BS2 8HW"
                }, 
                "name": "Bristol Heart Institute"
            }, 
            "investigator": {
                "last_name": "Elisa McAlindon, BMBS", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_groups": "1", 
        "overall_contact": {
            "email": "elisa.mcalindon@bristol.ac.uk", 
            "last_name": "Elisa McAlindon, BMBS", 
            "phone": "+441173425888"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": [
                "United Kingdom: National Research Ethics Service", 
                "United Kingdom: National Health Service"
            ]
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "The mass of myocardial oedema measured by CMR", 
            "safety_issue": "No", 
            "time_frame": "Day 2 following STEMI"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01897350"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Bristol", 
            "investigator_full_name": "Elisa McAlindon", 
            "investigator_title": "principle investigator", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Extra cellular volume", 
            "safety_issue": "No", 
            "time_frame": "Day 2 following STEMI"
        }, 
        "source": "University of Bristol", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Elisa McAlindon", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "July 2013"
    }
}